Class II

Medical Device Recall: DxC 500 AU Clinical Chemistry Analyzer, REF: C63519, and C63520 with affected software.

BECKMAN COULTER LABORATORY SYSTEMS (SUZHOU) CO., LTD. · January 10, 2025

Reason for Recall

Beckman Coulter has identified an issue which prevents the DxC 500 AU instrument from providing the correct onboard stability (Open Expiration) dates for assays that were loaded prior to a software upgrade (e.g. 1.3 to 1.4, 1.4 to 1.4.1, etc.). As a result, assays that have expired may still be used for sample processing, leading to inaccurate or erroneous patient test results. The issue only happens on assays loaded before instruments doing upgrades and does not impact new installation. It does not impact the assays loaded after upgrade.

Distribution

US: MA, CA, SC, LA, OK, GA, AL, TX, OR, ID, CO, MN, NY, MS, PA, WA, IL, MI, PR. OUS: Lebanon, Poland, Ghana, Spain, South Africa, Slovakia, Ghana, Croatia, Seychelles, Australia, Republic of Korea

States Affected

AL, CA, CO, GA, ID, IL, LA, MA, MI, MN, MS, NY, OK, OR, PA, SC, TX, WA

Quantity Affected

56

Source: FDA (openFDA Device Enforcement)

Recall number: Z-1233-2025

Status: ongoing

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.

BECKMAN COULTER LABORATORY SYSTEMS (SUZHOU) CO., LTD. Medical Device Recall: DxC 500 AU Clinical Chemistry Analyzer, REF: C63519, and C63520 with affected software. | SafeCheck